Meanwhile, the prognosis of BLCA patients enriched with mesenchymal stem cells does not depend on the expression of WDHD1, and BLCA patients who are not enriched with mesenchymal stem cells will have a poor prognosis due to high expression of WDHD1(Figure 5C). The gene discussed is WDHD1; the disease is bladder transitional cell carcinoma.